期刊文献+

CT灌注成像结合全肝增强扫描对41例中晚期肝癌患者行TACE疗效的评价 被引量:9

CT Perfusion Imaging Combined with Whole Liver Enhancement Scanned in Evaluating Curative Effect of 41 Patients Harbor Mid Advanced Stage Liver Cancer After TACE
原文传递
导出
摘要 目的评价CT灌注成像结合全肝增强扫描在中晚期肝癌患者行导管动脉化疗栓塞术(TACE)疗效的价值。方法 41例中晚期肝癌患者行TACE术后4周再行CT灌注扫描,计算肝血流量、肝血容量、平均通过时间、肝动脉分数及表面通透性等参数及基线图像,并于灌注扫描后即行全肝增强扫描。结果根据肝癌行TACE术后基线图像显示碘油在肿瘤区域的沉积形态,观察到在41患者中,碘油完全填充型1例、缺损型或环形10例、簇集型25例及稀少型5例;与肝癌再次行TACE治疗时肝动脉数字减影血管造影结果比较,两者诊断吻合率100%。各灌注参数显示碘油沉积区域肝癌组织血流灌注消失;非碘油沉积区域与正常肝组织比较,肝血流量、肝血容量及平均通过时间等参数差异均有统计学意义(P<0.01),而肝动脉分数及表面通透性等参数差异无统计学意义(P>0.05)。观察结果显示,全肝增强扫描可弥补CT灌注成像覆盖范围较小,无法全面了解全肝碘油填充情况的缺点;全肝增强扫描可提供肝癌及子灶大小、形态、密度、强化程度以及扫描范围其他脏器有无异常,是否有腹腔淋巴结转移等详细的临床资料。结论 CT灌注成像结合全肝增强扫描可判断中晚期肝癌患者行TACE疗效,对进一步治疗中晚期肝癌具有重要的临床指导价值。 Objective To evaluated the value of perfusion imaging combined with enhancement scanned of whole liver in patients with harbored mid advanced stage liver cancer after transarterial chemoembolization (TACE)treatment. Meth ods 41 patients with harbored mid advanced stage liver cancer underwent CT perfusion imaging and whole liver enhance ment scan before and 4 weeks after TACE treatment. Hepatic blood flow (HBF) , Hepatic blood volume (HBV) , Mean transit time( MTY), Hepatic artery fraction( HAF), Permeability of surface(PS) parameters, and the baseline image(BI) of CT were analyzed. Results According to the BI of CT scan after performed TACE indicated iodized oil deposition in lesions, the iodized oil deposition configuration appeared entireness filling in 1 case, ring form or incomplete filling in 10 cases, cluster in 25 cases, and sparsity in 5 cases. CT Perfusion parameters showed that the blood flow disappeared in io dized oil deposition in all the patients. HBF,HBV and MTT reduced significantly in non iodized oil deposited region com pared with normal liver tissue( P 〈 0.01 ), while HAF and PT has no difference between non iodized oil deposited region and normal liver tissue ( P 〉 0.05 ). Enhancement scan of whole liver might compensate the disadvantages of CT perfusion, such as lesser of coverage area. Enhancement scan of whole liver also provided advantage to observe the region, shape, density and strengthen degree of primary and secondary carcinoma, to observe invasion to visceral organs and lymphatic metastasis. Conclusion CT perfusion imaging combined with enhancement scan of whole liver could evaluate the curative effect of TACE, which has clinical guide value in optimizing therapy of midadvanced liver cancer patients.
出处 《临床放射学杂志》 CSCD 北大核心 2013年第12期1734-1738,共5页 Journal of Clinical Radiology
基金 国家自然科学基金项目(编号:81260306,81160261) 海南省重点科技项目(编号:DZXM20110038) 海南省卫生厅科研项目(编号:琼卫2011-71)
关键词 中晚期肝癌 经导管动脉化疗栓塞术 CT灌注成像 全肝增强扫描 Mid-advanced hepatocellular cancer Transarterial chemoembolization Computer tomography perfusionimage Enhancement scan of whole liver
  • 相关文献

参考文献3

二级参考文献13

  • 1王茂强,王仲朴,刘风永,王立军,李志坚,高育璈.膈下动脉参与肝肿瘤供血的介入治疗研究[J].中国医学影像技术,2003,19(11):1551-1553. 被引量:29
  • 2Yong-LiWang,Ming-HuaLi,Ying-ShengCheng,Hai-BingShi,Hai-LunFan.Influential factors and formation of extrahepatic collateral artery in unresectable hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(17):2637-2642. 被引量:24
  • 3Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
  • 4Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child- Turcotte criteria in medically treated cirrhosis. Hepatology,1984, 4: 430-435.
  • 5Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987, 7: 660-664.
  • 6Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 7Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Hepatology, 1996, 23: 164-176.
  • 8Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage or international normalized ratio?Hepatology, 1996, 24: 1392-1394.
  • 9Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology, 2001, 33:473-475.
  • 10McCaughan GW, Strasser SI. To MELD or not to MELD?Hepatology, 2001, 34: 215-216.

共引文献1097

同被引文献82

  • 1张媛,孙永光,高树明,韩向君.肝脏的CT灌注成像及其研究进展[J].CT理论与应用研究(中英文),2007,16(1):70-76. 被引量:8
  • 2凌昌全,刘庆,李东涛,岳小强,侯凤刚,朱德增,俞超芹,陈喆,翟笑枫,于洋.原发性肝癌常见中医基本证候定性诊断规范的研究[J].中西医结合学报,2005,3(2):95-98. 被引量:77
  • 3王景宇,王淑清,陈亮,冬冬.CT灌注成像在肝癌与肝血管瘤鉴别中的应用[J].临床肝胆病杂志,2006,22(6):455-457. 被引量:10
  • 4Jin-Young Choi,Jeong-Min Lee,Claude B.Sirlin CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma:Part II.Extracellular Agents,Hepatobiliary Agents,and Ancillary Imaging Features[J].Radiology,2014,273(1):30-50.
  • 5Hayri Ogul,Mecit Kantarci,Berhan Gen,et al.Perfusion CT imaging of the liver:review of clinical applications[J].Diagn Interv Radiol,2014,20(5):379-389.
  • 6Kim J H, Yoon H K, Ko G Y, et al. Nonresectable com- bined bepatocellular carcinoma and cholangiocarcinoma: Analysis of the response and prognostic factors after tran- scatheter arterial chemoembolization [ J]. Radiology, 2010,255 ( 1 ) :270-277.
  • 7Wang X, Li J, Peng Y, et al. Influence of preoperative transarterial chemoembolization on the prognosis for pa- tients with resectable hepatocellular carcinoma: a meta-a- nalysis of randomized trials [ J ]. Hepatogastroenterology, 2011,58 ( 107-108 ) :869-874.
  • 8陈高阳.肝动脉栓塞化疗联合中药治疗原发性肝癌临床观察[J].医学信息,2012,25(12):117-118.
  • 9周泽俊,胡永胜,高斌,巢惠民.多层螺旋CT图像伪影的分析[J].中国CT和MRI杂志,2008,6(5):72-73. 被引量:53
  • 10Liang Zhong Wen-Jing Wang Jian-Rong Xu.Clinical application of hepatic CT perfusion[J].World Journal of Gastroenterology,2009,15(8):907-911. 被引量:18

引证文献9

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部